-
AACR: micrornas regulating ...
-
Dr Michael Clarke - Stanford School of Medicine, USA, speaking at AACR 2009: micrornas regulating se...
-
IEO Interviews: Genome inst...
-
Marco Foiani is Full Professor of Molecular Biology at the Department of Biomolecular Sciences and B...
-
Professor Max Wicha - Breas...
-
Professor Max Wicha, Director, University of Michigan Comprehensive Cancer Center Breast cancer stem...
-
Dr. Angel Rodriguez - Findi...
-
Dr. Angel Rodriguez - Lester and Sue Smith Breast Centre, Baylor College of Medicine, Houston - Spea...
-
Prof. Aron Goldhirsch - Cli...
-
Professor Aron Goldhirsch, Director of the Department of Medicine at the European Institute of Oncol...
-
IEO Interviews: Two new met...
-
Dr Maria Pizzamiglio, Deputy Director, Breast Radiology Unit, European Institute of Oncology, Milan,...
-
Milan Breast Cancer Confere...
-
Dr Fedro Peccatori of the European Institute of Oncology, Milan, Italy, speaking at the 11th Milan B...
-
Colorectal cancer incidence...
-
Dr Otis Brawley, Chief Medical Officer of the American Cancer Society, talks about the growing incid...
-
Dr Anthony Letai - Breast C...
-
From San Antonio Breast Cancer Symposium Assistant Professor of Medicine, Haematologic Malignancies,...
ecancertv  |
(0) (0 Votes)
|
Views: (125)
Date: (07-04-10) Time: (00:04:20) |
Description: 2.5-Dimethyl-Celecoxib Exerts Antiangiogenic Effects on the Tumour Vasculature. Florence M. Hofman, Ph.D., professor of pathology, Keck School of Medicine, University of Southern California, speaking at AACR 2009, Denver.
